These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7529909)

  • 1. The anticonvulsant effect of the broad spectrum anticonvulsant loreclezole may be mediated in part by serotonin in rats: a microdialysis study.
    Dailey JW; Seo DO; Yan QS; Ko KH; Jo M; Jobe PC
    Neurosci Lett; 1994 Sep; 178(2):179-83. PubMed ID: 7529909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR).
    Dailey JW; Yan QS; Adams-Curtis LE; Ryu JR; Ko KH; Mishra PK; Jobe PC
    Life Sci; 1996; 58(4):259-66. PubMed ID: 8538363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships.
    Dailey JW; Reith ME; Yan QS; Li MY; Jobe PC
    Neurosci Lett; 1997 May; 227(1):13-6. PubMed ID: 9178847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
    Yan QS; Jobe PC; Cheong JH; Ko KH; Dailey JW
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):149-52. PubMed ID: 7527501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats.
    Yan QS; Jobe PC; Dailey JW
    Br J Pharmacol; 1995 Aug; 115(7):1314-8. PubMed ID: 7582562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats.
    Graumlich JF; McLaughlin RG; Birkhahn D; Shah N; Burk A; Jobe PC; Dailey JW
    Eur J Pharmacol; 1999 Mar; 369(3):305-11. PubMed ID: 10225367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
    Dailey JW; Yan QS; Mishra PK; Burger RL; Jobe PC
    J Pharmacol Exp Ther; 1992 Feb; 260(2):533-40. PubMed ID: 1738103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+.
    Dailey JW; Reith ME; Yan QS; Li MY; Jobe PC
    Eur J Pharmacol; 1997 Jun; 328(2-3):153-62. PubMed ID: 9218697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo studies on the mechanism of action of the broad spectrum anticonvulsant loreclezole.
    Ashton D; Fransen J; Heeres J; Clincke GH; Janssen PA
    Epilepsy Res; 1992 Mar; 11(1):27-36. PubMed ID: 1563336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis.
    Yan QS; Jobe PC; Dailey JW
    Brain Res; 1993 Apr; 610(1):24-31. PubMed ID: 8518928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response.
    Dailey JW; Cheong JH; Ko KH; Adams-Curtis LE; Jobe PC
    Neurosci Lett; 1995 Aug; 195(2):77-80. PubMed ID: 7478272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies on the broad spectrum anticonvulsant loreclezole in the hippocampus.
    Ashton D; Willems R
    Epilepsy Res; 1992 Apr; 11(2):75-88. PubMed ID: 1618181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
    Yan QS; Mishra PK; Burger RL; Bettendorf AF; Jobe PC; Dailey JW
    J Pharmacol Exp Ther; 1992 May; 261(2):652-9. PubMed ID: 1374472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
    Yan QS; Jobe PC; Dailey JW
    Eur J Pharmacol; 1994 Jan; 252(1):105-12. PubMed ID: 8149989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of GABAbeta2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole.
    Groves JO; Guscott MR; Hallett DJ; Rosahl TW; Pike A; Davies A; Wafford KA; Reynolds DS
    Eur J Neurosci; 2006 Jul; 24(1):167-74. PubMed ID: 16882014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of loreclezole on epileptic activity and on EEG and behaviour in rats with absence seizures.
    Ates N; van Luijtelaar EL; Drinkenburg WH; Vossen JM; Coenen AM
    Epilepsy Res; 1992 Oct; 13(1):43-8. PubMed ID: 1478197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.
    Browning RA; Wood AV; Merrill MA; Dailey JW; Jobe PC
    Eur J Pharmacol; 1997 Oct; 336(1):1-6. PubMed ID: 9384247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant profile of MDL 27,266: an orally active, broad-spectrum anticonvulsant agent.
    White HS; Patel S; Meldrum BS
    Epilepsy Res; 1992 Sep; 12(3):217-26. PubMed ID: 1396547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin.
    Clinckers R; Gheuens S; Smolders I; Meurs A; Ebinger G; Michotte Y
    Epilepsia; 2005 Jun; 46(6):828-36. PubMed ID: 15946324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs).
    Gareri P; Condorelli D; Belluardo N; Russo E; Loiacono A; Barresi V; Trovato-Salinaro A; Mirone MB; Ferreri Ibbadu G; De Sarro G
    Neuropharmacology; 2004 Dec; 47(8):1205-16. PubMed ID: 15567430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.